Dr. Weiss will work with chief medical officer Dr. Bridget Martell to support the development of Juniper's product portfolio, providing medical, clinical and regulatory expertise for current and future product candidates leveraging its delivery technologies.
"We are thrilled to have recruited such a medical talent to Juniper Pharmaceuticals as we advance our high-value pipeline to address acute and chronic women's health conditions into later stages of clinical development," said Frank Condella, chief executive officer. "Herman brings that right balance of clinical acumen, business sense, regulatory experience, and deep understanding of the continued needs in women's health."
Dr. Weiss joins Juniper from Teva Pharmaceutical Industries, Ltd., where he served as Global Medical Director Women's Health and Bone Health. Dr. Weiss was responsible for the global launch of seven products in the contraception, urology, and infertility space, and designed, implemented and oversaw multiple late-stage clinical trials. He also provided all medical due diligence for business development projects.